Octagos is thrilled to announce its selection to join the Microsoft for Startups Pegasus Program, an invite-only initiative designed for high-growth companies that are transforming industries with AI (artificial intelligence), healthcare innovation, and cybersecurity breakthroughs.
This recognition places the company among a select group of innovators and gives Octagos access to Microsoft’s global enterprise network, world-class go-to-market experts, and Azure’s secure, AI-optimized cloud infrastructure, a major step forward in its mission to transform remote cardiac care.
Why This Matters
Remote cardiac monitoring is one of the fastest-evolving areas in digital health, but it comes with significant challenges, fragmented data, overwhelming clinical workloads, and delayed interventions. Octagos was built to solve these problems.
Since launching in 2020, Octagos has focused on making cardiac monitoring faster, smarter, and more efficient, helping clinics improve patient care and reduce workloads, achieving:
- 1 billion+ transmission pages processed into AI-powered clinical reports.
- 200+ EHR integrations completed, with clinics live in under four weeks.
- 65% reduction in unnecessary transmissions, freeing providers to focus on high-risk patients.
Being part of the Pegasus Program validates the impact Octagos has already made, and it accelerates what comes next.
What Microsoft Says About the Partnership
“Octagos is exactly the kind of innovative company the Microsoft for Startups Pegasus Program was built to support,” said Sally Ann Frank, global lead of health & life sciences,
Microsoft for Startups. “Their AI-driven solution empowers providers with timely, actionable insights, advancing cardiac care and enabling faster, more effective interventions.”
What’s Next for Octagos?
The Pegasus partnership is just one piece of the company’s broader growth strategy. In the past year, Octagos has:
- Launched the OctaLink Clinic Mobile App for on-the-go review and e-signature of billable events.
- Expanded real-time support for ambulatory monitors, heart failure diagnostics, and RPM systems.
- Invested deeply in AI-enhanced clinical reporting and engineering infrastructure.
- Grown our leadership team across AI, product, and customer success.
- Secured institutional investment from Morgan Stanley to accelerate national expansion.
Shaping the Future of Cardiac Remote Monitoring
“This collaboration accelerates our mission to transform remote cardiac care and enhance the efficiency and quality of patient monitoring,” said Dr. Shanti Bansal, founder and CEO of Octagos.
By unifying cardiac data, reducing clinical burden, and delivering actionable AI insights, Octagos is helping clinics operate more efficiently, without compromising care quality. The Pegasus Program will help scale these efforts even further, connecting more providers with the tools they need to improve outcomes and save lives.
Read the press release here.